OSCR
Oscar Health, Inc.
OSCR has the edge over PARK overall, supported by stronger fundamentals and stronger modeled upside.
PARK
Park Dental Partners, Inc. Common Stock
PARK has lower modeled downside risk, despite its lower overall score.
OSCR Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Strong | |
| Strong |
OSCR's revenue, profitability, cash flow and balance sheet are all currently healthy.
PARK Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Under pressure | |
| Strong |
PARK's balance sheet is currently strong, and its revenue is stable, but its profitability and cash flow are under pressure.
OSCR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $31.94 | — |
| Current | 13x | $31.94 | — |
| Cheap | 21x | $52.73 | +65% |
| Fair | 35x | $87.23 | +173% |
| Expensive | 130x | $322 | +907% |
Historical ranges are pointers, not guarantees.
OSCR's PE is 13x, but its earnings don't support one, so it isn't a reliable read right now.
PARK PE Valuation
PARK has no meaningful PE right now: it lost money over the past year.
OSCR Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for OSCR, with profitability improving.
PARK Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for PARK, with profitability improving.
OSCR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.61 | +5.6% |
| Q3 2026 | $2.47 | +$3.47 |
| Q2 2026 | $1.45 | +$2.14 |
| Q1 2026 | -$0.54 | -235% |
| Q4 2025 | -$1.69 | -1790% |
| Q3 2025 | -$1.00 | -$0.92 |
| Q2 2025 | -$0.69 | -$0.54 |
| Q1 2025 | $0.40 | +$0.82 |
| Q4 2024 | $0.10 | +$1.32 |
OSCR has the edge over PARK on earnings quality, reporting a profit while its opponent remains loss making.
PARK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.42 | — |
| Q3 2026 | -$0.95 | -177% |
| Q2 2026 | -$0.91 | -194% |
| Q1 2026 | -$0.52 | -133% |
| Q4 2025 | -$0.06 | -102% |
PARK has swung to a loss: it lost $0.95 per share over the past year, after a profit the year before.
OSCR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $5.1B | +72% |
| Q2 2026 | $4.9B | +70% |
| Q1 2026 | $4.6B | +53% |
| Q4 2025 | $2.8B | +17% |
| Q3 2025 | $3B | +23% |
| Q2 2025 | $2.9B | +29% |
| Q1 2025 | $3B | +42% |
| Q4 2024 | $2.4B | +67% |
OSCR has the edge over PARK on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 3.5% | +7.8 points |
| Q2 2026 | 8% | +16 points |
| Q1 2026 | 15% | +5.4 points |
| Q4 2025 | -12% | -5.7 points |
| Q3 2025 | -4.3% | -2.3 points |
| Q2 2025 | -8.1% | -11 points |
| Q1 2025 | 9.8% | +1.1 points |
| Q4 2024 | -6.2% | +4 points |
OSCR has the edge over PARK on profitability, with a higher operating margin.
PARK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $64.9M | +6% |
| Q2 2026 | $66.2M | +8.5% |
| Q1 2026 | $62.7M | +2.7% |
| Q4 2025 | $61.2M | +7.5% |
| Q3 2025 | $61.3M | +11% |
| Q2 2025 | $61M | +3.8% |
| Q1 2025 | $61M | +3.8% |
PARK's revenue has grown year over year every quarter since early 2025: $65M last quarter, up 6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -0.2% | -3.1 points |
| Q2 2026 | 1.9% | -3.6 points |
| Q1 2026 | -3% | -8.5 points |
| Q4 2025 | -13% | +15 points |
| Q3 2025 | 2.9% | +0.6 points |
| Q2 2025 | 5.5% | +0.3 points |
| Q1 2025 | 5.5% | +0.3 points |
| Q4 2024 | -28% | N/A |
PARK's operating margin was −0.2% last quarter, down 3.1 points from the same quarter a year ago.
OSCR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.2B | -$238.2M |
| Q2 2026 | $2.1B | +316% |
| Q1 2026 | $2.6B | +200% |
| Q4 2025 | $662.8M | +95% |
| Q3 2025 | -$973.7M | -$466M |
| Q2 2025 | $499.8M | +2.1% |
| Q1 2025 | $869.5M | +38% |
| Q4 2024 | $340M | +17% |
OSCR has the edge over PARK on cash flow, with more consistent year-over-year improvement.
PARK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$569K | -110% |
| Q2 2026 | $2.2M | +26% |
| Q1 2026 | $2.7M | -21% |
| Q4 2025 | -$491K | -123% |
| Q3 2025 | $5.6M | -5.6% |
| Q2 2025 | $1.8M | +53% |
| Q1 2025 | $3.4M | +196% |
PARK usually generates cash, though not every quarter: the latest was −$569,000, but it generated $4M over the past year.
OSCR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.9% | +13M shares |
| 1 year | +34% | +87.2M shares |
| 3 years | +55% | +123M shares |
| 5 years | +66% | +138M shares |
| Available history | +71% | +143M shares |
OSCR has the edge over PARK on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
PARK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +2% | +126K shares |
| 1 year | +55% | +2.3M shares |
PARK has 6M diluted shares, up 55% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q3 2025 | $308,000 |
| Q2 2025 | $242,000 |
| Q1 2025 | $154,000 |
| Q4 2024 | — |
| Q3 2024 | $154,000 |
| Q2 2024 | — |
| Q1 2024 | — |
OSCR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -4.2x | Net Cash |
| Q2 2026 | -5.5x | Net Cash |
| Q1 2026 | -110.0x | Net Cash |
| Q1 2025 | -9.7x | Net Cash |
| Q4 2024 | -13.7x | Net Cash |
| Q3 2024 | -10.1x | Net Cash |
| Q2 2024 | -24.0x | Net Cash |
| Q1 2024 | -217.7x | Net Cash |
OSCR has more cash than debt.
PARK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -27.0x | Net Cash |
| Q1 2026 | -2.8x | Net Cash |
| Q4 2025 | -2,580.6x | Net Cash |
| Q3 2025 | 2.6x | Moderate |
| Q2 2025 | 3.1x | Elevated |
| Q1 2025 | 3.2x | Elevated |
PARK has the edge over OSCR on leverage, with a lower net debt burden relative to earnings.
OSCR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.7 | Neutral |
| Stochastic | 44.9 | Neutral |
OSCR's weekly RSI is 59 (neutral) and its Stochastic is 45 (neutral).
PARK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.6 | Neutral |
| Stochastic | 32.0 | Neutral |
PARK's weekly RSI is 58 (neutral) and its Stochastic is 32 (neutral).
OSCR PE vs Healthcare Sector
| Metric | OSCR | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 26x | 50% below |
| PE % | 3 | 35 | 32 pts below |
OSCR is trading at 13x earnings, a 50% discount to the Healthcare sector's median of 26x, though its earnings don't support one.
PARK PE vs Healthcare Sector
PARK has no meaningful PE right now: it lost money over the past year.
OSCR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $31.2 | 2.3% above |
| 20 week MA | $31.1 | 2.8% above |
| 50 week MA | $22.9 | 39% above |
| 100 week MA | $19.3 | 65% above |
| 200 week MA | $15.5 | 106% above |
PARK has stronger trend alignment. OSCR is above 5 of 5 weekly averages versus PARK above 3 of 3.
PARK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $20.1 | 5.3% above |
| 20 week MA | $20.3 | 4.4% above |
| 50 week MA | $18.5 | 15% above |
PARK is in an uptrend: it's above all three of its weekly moving averages, and 15% above its 50-week average.
OSCR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $31.0 | $8.02 | -74% |
| 2022 | $8.02 | $2.21 | -72% |
| 2023 | $2.21 | $9.15 | +314% |
| 2024 | $9.15 | $13.8 | +51% |
| 2025 | $13.8 | $14.9 | +8% |
| 2026 YTD | $14.9 | $31.9 | +114% |
OSCR has the edge over PARK on returns for 2026, with the stronger performance.
PARK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $13.3 | $14.7 | +10% |
| 2026 YTD | $14.7 | $21.2 | +44% |
PARK has finished every year since 2025 higher, and it's up 44% so far in 2026.